MedTech News
.................... by Andrew Celentano
FDA clears NeurAxis’ neurostimulator for abdominal pain
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses functional dyspepsia.
Siemens Healthineers Presents Photon-Counting CT Scanner Designed for Radiation Therapy
Novel technology delivers enhanced image contrast and resolution for confident decisions
Major study examines endoscopies that fail to detect esophageal cancer
An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect cancer of the esophagus. But sometimes, an endoscopy can miss esophageal cancer, which doesn’t get detected until weeks or months later.
‘Guided missile’ drug molecule seeks out and destroys cancer’s genetic lifeline
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.
AI helps scientists correct mistakes in medical studies
Randomized, controlled clinical trials are crucial for telling whether a new treatment is safe and effective. But often scientists don’t fully report the details of their trials in a way that allows other researchers to gauge how well they designed and conducted those studies.
Decades-old asthma theory challenged: Newly discovered molecules may be real drivers of disease
For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.
Hydrogen gas found to play key role in supporting gut health
Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making flatulence ignite, hydrogen also has a positive role supporting gut health.
Successful experiments reprogram rogue T cells for targeted autoimmune disease therapy
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.